Scotiabank analyst Kevin Krishnaratne raised the firm’s price target on Docebo to $65 from $60 and keeps an Outperform rating on the shares. The company’s Q4 was a strong finish to the year with revenues and adjusted EBITDA ahead of expectations, the analyst tells investors in a research note. The firm has confidence in Docebo’s competitive positioning in enterprise, its “unique opportunity: in external/hybrid use cases, and sees upside as the year progresses on its many initiatives including government, new product launches and international opportunities.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on DCBO: